{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:16:53Z","timestamp":1730783813466,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"DOI":"10.7759\/cureus.73008","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:43:08Z","timestamp":1730763788000},"source":"Crossref","is-referenced-by-count":0,"title":["A Low Forced Vital Capacity (FVC)\/Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) Ratio Increases Clinical Suspicion for Fibrotic Hypersensitivity Pneumonitis (FHP) Over Idiopathic Pulmonary Fibrosis (IPF)"],"prefix":"10.7759","author":[{"given":"Tannam S","family":"Vongvivitpatana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop M","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu G","year":"2020","unstructured":"Raghu G, Remy-Jardin M, Ryerson CJ, et al.. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2020, 202:e36-69. 10.1164\/rccm.202005-2032ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu G","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al.. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018, 198:e44-68. 10.1164\/rccm.201807-1255ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201611-2201PP","article-title":"Hypersensitivity pneumonitis: perspectives in diagnosis and management","volume":"196","author":"Vasakova M","year":"2017","unstructured":"Vasakova M, Morell F, Walsh S, Leslie K, Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017, 196:680-9. 10.1164\/rccm.201611-2201PP","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2453061881","article-title":"Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT","volume":"246","author":"Silva CI","year":"2008","unstructured":"Silva CI, M\u00fcller NL, Lynch DA, et al.. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology. 2008, 246:288-97. 10.1148\/radiol.2453061881","journal-title":"Radiology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00531-2019","article-title":"Variable utility of mosaic attenuation to\u00a0distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis","volume":"54","author":"Barnett J","year":"2019","unstructured":"Barnett J, Molyneaux PL, Rawal B, et al.. Variable utility of mosaic attenuation to\u00a0distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. Eur Respir J. 2019, 54:14-6. 10.1183\/13993003.00531-2019","journal-title":"Eur Respir J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham BL","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al.. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019, 200:e70-88. 10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham BL","year":"2017","unstructured":"Graham BL, Brusasco V, Burgos F, et al.. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017, 49:4-6. 10.1183\/13993003.00016-2016","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00513-2020","article-title":"A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension","volume":"56","author":"Ghio S","year":"2020","unstructured":"Ghio S, Mercurio V, Fortuni F, et al.. A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension. Eur Respir J. 2020, 56:26-8. 10.1183\/13993003.00513-2020","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert M","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al.. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022, 43:3618-731. 10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-6","article-title":"Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension","volume":"14","author":"Farha S","year":"2013","unstructured":"Farha S, Laskowski D, George D, Park MM, Tang WH, Dweik RA, Erzurum SC. Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. Respir Res. 2013, 14:6. 10.1186\/1465-9921-14-6","journal-title":"Respir Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.1.9001318","article-title":"Adjustment of DLCO for hemoglobin concentration","volume":"155","author":"Marrades RM","year":"1997","unstructured":"Marrades RM, Diaz O, Roca J, et al.. Adjustment of DLCO for hemoglobin concentration. Am J Respir Crit Care Med. 1997, 155:236-41. 10.1164\/ajrccm.155.1.9001318","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202302-0310ST","article-title":"Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement","volume":"207","author":"Bhakta NR","year":"2023","unstructured":"Bhakta NR, Bime C, Kaminsky DA, et al.. Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement. Am J Respir Crit Care Med. 2023, 207:978-95. 10.1164\/rccm.202302-0310ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley B","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, et al.. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012, 156:684-91. 10.7326\/0003-4819-156-10-201205150-00004","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson CJ","year":"2014","unstructured":"Ryerson CJ, Vittinghoff E, Ley B, et al.. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014, 145:723-8. 10.1378\/chest.13-1474","journal-title":"Chest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1183\/1393003.congress-2017.PA861","article-title":"Evaluation of FVC\/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases","volume":"50","author":"Hoda ED","year":"2017","unstructured":"Hoda ED, Mohamed-Hussein AR. Evaluation of FVC\/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases. Eur Respir J. 2017, 50:861. 10.1183\/1393003.congress-2017.PA861","journal-title":"Eur Respir J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1573-9","article-title":"Utility of FVC\/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension","volume":"12","author":"Donato L","year":"2017","unstructured":"Donato L, Giovanna Elisiana C, Giuseppe G, et al.. Utility of FVC\/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension. Intern Emerg Med. 2017, 12:319-26. 10.1007\/s11739-016-1573-9","journal-title":"Intern Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01130-6","article-title":"FVC\/D(LCO) identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD","volume":"28","author":"Li Y","year":"2023","unstructured":"Li Y, Zhang R, Shan H, et al.. FVC\/D(LCO) identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD. Eur J Med Res. 2023, 28:174. 10.1186\/s40001-023-01130-6","journal-title":"Eur J Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.029","article-title":"Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis","volume":"151","author":"Morisset J","year":"2017","unstructured":"Morisset J, Johannson KA, Vittinghoff E, et al.. Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. Chest. 2017, 151:619-25. 10.1016\/j.chest.2016.10.029","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6020051","article-title":"Prognosis and follow-up of idiopathic pulmonary fibrosis","volume":"6","author":"Fern\u00e1ndez Fabrellas E","year":"2018","unstructured":"Fern\u00e1ndez Fabrellas E, Peris S\u00e1nchez R, Sabater Abad C, Juan Samper G. Prognosis and follow-up of idiopathic pulmonary fibrosis. Med Sci (Basel). 2018, 6:14-6. 10.3390\/medsci6020051","journal-title":"Med Sci (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0205","article-title":"Comparing racial differences in emphysema prevalence among adults with normal spirometry: a secondary data analysis of the CARDIA Lung Study","volume":"175","author":"Liu GY","year":"2022","unstructured":"Liu GY, Khan SS, Colangelo LA, et al.. Comparing racial differences in emphysema prevalence among adults with normal spirometry: a secondary data analysis of the CARDIA Lung Study. Ann Intern Med. 2022, 175:1118-25. 10.7326\/M22-0205","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/290452-a-low-forced-vital-capacity-fvcdiffusing-capacity-of-the-lung-for-carbon-monoxide-dlco-ratio-increases-clinical-suspicion-for-fibrotic-hypersensitivity-pneumonitis-fhp-over-idiopathic-pulmonary-fibrosis-ipf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:43:09Z","timestamp":1730763789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/290452-a-low-forced-vital-capacity-fvcdiffusing-capacity-of-the-lung-for-carbon-monoxide-dlco-ratio-increases-clinical-suspicion-for-fibrotic-hypersensitivity-pneumonitis-fhp-over-idiopathic-pulmonary-fibrosis-ipf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.73008","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}